article thumbnail

STAT’s most memorable photos of 2023

STAT

As we look back at 2023 in photographs, the faces of so many stand out: investors and researchers moving their industries forward, a man working to escape the cycle of addiction, a physician who has taken his career on the road after the abortions he provides were made illegal in his home state.

301
301
article thumbnail

Here are the worst biopharma CEOs of 2023

STAT

If David Ricks is the best biopharma CEO of 2023 , then Pfizer CEO Albert Bourla is, unfortunately, the worst. Pfizer is this year’s anti-Eli Lilly. My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability.

362
362
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ALiEM AIR Series | Trauma 2023 Module

ALiEM - Pharm Pearls

2023.02.011 , PMID 36967275 Author information Chris Belcher, MD Editor, ALiEM AIR Series Assistant Professor and Assistant Program Director Department of Emergency Medicine University of Kentucky College of Medicine | Twitter | The post ALiEM AIR Series | Trauma 2023 Module appeared first on ALiEM. Ann Emerg Med. 2023;82(1):55-65.

Labelling 206
article thumbnail

Health data breaches hit an all-time high in 2023

STAT

It’s the standard notice many health care organizations are required to provide when your protected health information gets exposed — and in 2023, data leaks, hacks, and mishandling led more of them to be delivered than ever before.

HIPAA 357
article thumbnail

STAT+: The biggest health care deals of 2023

STAT

That trend of vertical integration was on full display in 2023, a year when the country’s biggest pharmacy chain bought a primary care provider, and the biggest private insurer branched further into home health. Companies that were once just insurers or just pharmacies are tacking on new business lines.

Hospitals 290
article thumbnail

STAT+: Here are the best biopharma CEOs of 2023

STAT

Let’s get right to the main course: David Ricks of Eli Lilly is the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023. More on those high-achieving folks later. What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much.

300
300
article thumbnail

STAT+: Lasers, cardiology, clinical trials: 2023’s top private equity targets

STAT

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

Hospitals 227